Author:
Sztaricskai Ferenc,Sum Anita,Roth Erzsébet,Pelyvás István F,Sándor Szabolcs,Batta Gyula,Herczegh Pál,Reményi Judit,Miklán Zsanett,Hudecz Ferenc
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology
Reference21 articles.
1. Arlandini A, Vigevani A, Arcamone F . Interaction of new derivatives of daunorubicin and doxorubicin with DNA. Part II. Farmaco Ed Sci 35: 65–78 ( 1980)
2. Arcamone F . Doxorubicin Anticancer Antibiotics, Vol. 17. Academic Press, New York ( 1981)
3. Young CW, Wittes RE . Clinical evaluation of three new anthracyclines: epirubicin, idarubicin and esorubicin. In: Ogawa M, Muggia FM, Rozencweig M (eds.). Adriamycin: Its Expanding Role in Cancer Treatment. Excerpta Medica, Tokyo, pp. 479–499 ( 1984)
4. Fuchs EF, Horton D, Weckerle W . Synthesis of 7-O-(2,6-dideoxy-α-L-lyxo-hexopyranosyl)daunomicinone, a functional analog of daunorubicin. Carbohydrate Res 57: c36–c39 ( 1977)
5. Sztaricskai F, Menyhárt M, Bognár R . 7-O-(3-Azido-2,3,6-trideoxy-α- and β-L-ribo-hexopyranosyl)carminomycinone: novel analogues of anthracycline antibiotics. Carbohydrate Res 100: c14–c16 ( 1982)
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献